– ABI-5366 is currently being evaluated in ongoing Phase 1b clinical trial with interim proof-of-concept data expected in fall 2025 – SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- ...
Unveiling a global crisis: groundbreaking research highlights the immense impact of HSV infections on health, urging a shift towards vaccine innovation and prevention measures. Study: Estimated global ...
The herpes IgG test is a blood test used to diagnose herpes simplex virus (HSV). This includes HSV-1, the type most commonly linked to cold sores, and HSV-2, the type mainly associated with genital ...
Assembly Biosciences Inc (($ASMB)) announced an update on their ongoing clinical study. Study Overview: Assembly Biosciences Inc. is conducting a ...
Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...
Infection with HSV can cause oral or genital warts, but it can also be fully asymptomatic. There are two types of HSV: herpes type 1 (HSV-1), mainly spread through oral contact herpes type 2 (HSV-2), ...
Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage ...